“Every one of us is united by a shared vision to give all cancer patients more —more ways to treat their cancer, more quality in their lives, more time. MSD’s unwavering commitment is what we believe will bring us a closer to our goal of bringing life to more patients with cancer.”

Sophie Opdyke, Senior Vice President, Global Oncology Marketing, MSD.

“At Sanofi, we recognise that every cancer patient is unique. We are inspired by their resilience in our mission to develop novel treatment options, expand access to therapies and provide comprehensive patient support resources. We are proud to be a partner of World Cancer Day and the United by Unique campaign to find solutions for the future of cancer care.” 

Olivier Nataf, Global Head, Oncology Franchise, Sanofi

“Throughout my career as a physician, I always tried to ensure that I saw each patient as more than their diagnosis and more than their disease. I really tried to see them – their struggles, their fears, their resilience, their hopes. This World Cancer Day and every day, Amgen joins UICC in our shared commitment to treat the person, not just the disease. Everyone’s journey is different. Let’s work together to better serve patients by embracing unique perspectives so we can ensure people are at the heart of every solution.” 

Darryl Sleep, M.D., Head, Global Public Health, Amgen

“Under our corporate philosophy, “Dedicated to the Fight against Disease and Pain,” we have been delivering medicines passionately that bring true benefits to cancer patients. However, we are aware that there are still many issues that cannot be resolved with medicines alone. In collaboration with UICC and other partners, we will continue to devote our energies to not only treating cancer but also solving other remaining issues.”

Toichi Takino, President and Chief Operating Officer, Ono Pharmaceutical Co., Ltd.

“World Cancer Day reminds us that every cancer journey is unique, yet we are united in the pursuit of better care and outcomes. At Jazz Pharmaceuticals, we champion a people-centered approach to care. We are proud to support this movement to amplify voices and inspire collective progress to make a meaningful difference for people impacted by cancer and their families.”

Robert Iannone, M.D., M.S.C.E. Executive Vice President, Global Head of Research and Development and Chief Medical Officer, Jazz Pharmaceuticals.